Dublin, July 11, 2024 (GLOBE NEWSWIRE) -- The "Epigenetics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
The global market for Epigenetics is estimated at US$1.6 Billion in 2023 and is projected to reach US$3.9 Billion by 2030, growing at a CAGR of 13.3% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. 
The growth in the epigenetics market is driven by several factors, including increasing investments in research and development, the rising prevalence of complex diseases, and advancements in technology. Pharmaceutical and biotechnology companies are investing heavily in epigenetics research to discover new drug targets and develop epigenetic therapies. The rising incidence of cancers, neurological disorders, and autoimmune diseases, which are often associated with epigenetic dysregulation, is fueling demand for epigenetic research and diagnostics.
Advancements in high-throughput technologies and bioinformatics tools are making it easier and more cost-effective to study epigenetic modifications, thus accelerating research efforts. Additionally, the integration of epigenetics with other omics technologies, such as genomics, transcriptomics, and proteomics, is providing comprehensive insights into disease mechanisms and identifying novel biomarkers for early diagnosis and personalized treatment.
The increasing collaboration between academic institutions, research organizations, and industry players is also fostering innovation and expanding the application of epigenetic discoveries in clinical settings. Overall, the epigenetics market is poised for significant growth, driven by technological advancements, rising disease prevalence, and substantial research investments.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Epigenetics Kits segment, which is expected to reach US$1.9 Billion by 2030 with a CAGR of a 14.6%. The Epigenetics Reagents segment is also set to grow at 13.4% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $449.9 Million in 2023, and China, forecasted to grow at an impressive 12.5% CAGR to reach $598.9 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as Abcam PLC, Active Motif, Inc., CellCentric, and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 299 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value (USD) in 2023 | $1.6 Billion |
| Forecasted Market Value (USD) by 2030 | $3.9 Billion |
| Compound Annual Growth Rate | 13.3% |
| Regions Covered | Global |
MARKET OVERVIEW
- Influencer Market Insights
- Global Economic Update
- Epigenetics - Global Key Competitors Percentage Market Share in 2024 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
MARKET TRENDS & DRIVERS
- Advances in Epigenetic Technologies Propel Market Growth
- Increasing Investment in Epigenetic Research Strengthens Business Case for Innovation
- Rising Prevalence of Cancer Generates Demand for Epigenetic Therapies
- Expanding Applications in Personalized Medicine Drives Adoption of Epigenetic Solutions
- Technological Innovations in Sequencing Techniques Throw the Spotlight on Epigenetic Discoveries
- Growing Interest in Epigenetic Biomarkers Spurs Market Expansion
- Pharmaceutical Companies` Focus on Epigenetic Drug Development Accelerates Demand
- Emerging Role of Epigenetics in Disease Prevention and Management Expands Addressable Market
- Increasing Awareness of Epigenetic Mechanisms in Aging Drives Research Funding
- Adoption of Epigenetic Screening in Clinical Diagnostics Sustains Market Growth
- Advances in Computational Biology and Bioinformatics Enhance Epigenetic Research Capabilities
- Integration of Epigenetic Data in Drug Development Strengthens the Business Case for Personalized Therapies
- Innovations in Epigenetic Editing Technologies Propel Research and Commercial Interest
- Development of Novel Epigenetic Therapeutics for Rare Diseases Generates New Opportunities
- Increased Focus on Environmental Epigenetics Spurs Research and Market Growth
- Rising Demand for Non-Invasive Epigenetic Testing Methods Drives Adoption
- Epigenetic Modifications as Therapeutic Targets Strengthens Business Case for New Drug Development
- Advancements in Single-cell Epigenomics Expand Research Capabilities and Market Potential
- The Role of Epigenetics in Immunotherapy Throws the Spotlight on Novel Treatment Approaches
- Consumer Interest in Epigenetic-based Health and Wellness Solutions Spurs Market Demand
- Integration of AI and Machine Learning in Epigenetics Research Enhances Data Analysis and Accelerates Discoveries
FOCUS ON SELECT PLAYERS
- Abcam PLC
- Active Motif, Inc.
- CellCentric
- Diagenode SA
- Eisai Co., Ltd.
- F. Hoffmann-La Roche AG
- Illumina, Inc.
- MilliporeSigma
- Novartis International AG
- Oncolys BioPharma Inc.
- QIAGEN GmbH
- Syndax Pharmaceuticals, Inc.
- Thermo Fisher Scientific, Inc.
- Valirx Plc
- Zymo Research Corporation
For more information about this report visit https://www.researchandmarkets.com/r/qcpvi7
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
